The cytolytic molecules Fas ligand and TRAIL are required for murine thymic graft-versus-host disease-Reference-Cited by-同舟云学术

The cytolytic molecules Fas ligand and TRAIL are required for murine thymic graft-versus-host disease

Published:2010-01-04 Issue:1 Volume:120 Page:343-356
ISSN:0021-9738
Container-title:Journal of Clinical Investigation
language:en
Short-container-title:J. Clin. Invest.

Author:

Na Il-Kang,Lu Sydney X.,Yim Nury L.,Goldberg Gabrielle L.,Tsai Jennifer,Rao Uttam,Smith Odette M.,King Christopher G.,Suh David,Hirschhorn-Cymerman Daniel,Palomba Lia,Penack Olaf,Holland Amanda M.,Jenq Robert R.,Ghosh Arnab,Tran Hien,Merghoub Taha,Liu Chen,Sempowski Gregory D.,Ventevogel Melissa,Beauchemin Nicole,van den Brink Marcel R.M.

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Reference62 articles.

1. Late infections after allogeneic bone marrow transplantations: comparison of incidence in related and unrelated donor transplant recipients

2. Long-Term Survival and Late Deaths after Allogeneic Bone Marrow Transplantation

3. IMPACT OF T-CELL DEPLETION ON OUTCOME OF ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR STANDARD-RISK LEUKAEMIAS

4. Recovery of immune reactivity after T-cell–depleted bone marrow transplantation depends on thymic activity

5. Reconstitution of the T-Cell Compartment After Bone Marrow Transplantation: Restoration of the Repertoire by Thymic Emigrants

Cited by 61 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The potential role of the thymus in immunotherapies for acute myeloid leukemia;Frontiers in Immunology;2023-02-06

2. Isolation of Thymus Stromal Cells from Human and Murine Tissue;Methods in Molecular Biology;2022-10-19

3. Retention of Donor T Cells in Lymphohematopoietic Tissue and Augmentation of Tissue PD-L1 Protection for Prevention of GVHD While Preserving GVL Activity;Frontiers in Immunology;2022-05-23

4. Chimerism-Based Tolerance to Kidney Allografts in Humans: Novel Insights and Future Perspectives;Frontiers in Immunology;2022-01-05

5. Nonclassical manifestations of acute GVHD;Blood;2021-12-02